Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,733 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy.
Matsumoto S, Nakazawa G, Ohno Y, Ishihara M, Sakai K, Nakamura N, Murakami T, Natsumeda M, Kabuki T, Shibata A, Kida K, Konishi M, Ishii S, Ikeda T, Ikari Y. Matsumoto S, et al. Among authors: shibata a. ESC Heart Fail. 2020 Dec;7(6):4172-4181. doi: 10.1002/ehf2.13042. Epub 2020 Oct 10. ESC Heart Fail. 2020. PMID: 33037750 Free PMC article.
Contrast-enhanced computed tomography with myocardial three-dimensional printing can guide treatment in symptomatic hypertrophic obstructive cardiomyopathy.
Hamatani Y, Amaki M, Kanzaki H, Yamashita K, Nakashima Y, Shibata A, Okada A, Takahama H, Hasegawa T, Shimahara Y, Sugano Y, Fujita T, Shiraishi I, Yasuda S, Kobayashi J, Anzai T. Hamatani Y, et al. Among authors: shibata a. ESC Heart Fail. 2017 Nov;4(4):665-669. doi: 10.1002/ehf2.12178. Epub 2017 Jul 4. ESC Heart Fail. 2017. PMID: 29154429 Free PMC article.
Soluble urokinase-type plasminogen activator receptor represents exercise tolerance and predicts adverse cardiac events in patients with heart failure.
Ishikawa H, Izumiya Y, Shibata A, Ichikawa Y, Yamaguchi T, Yamaguchi Y, Kitada R, Iwata S, Ehara S, Tomita S, Hanatani A, Yoshiyama M. Ishikawa H, et al. Among authors: shibata a. Heart Vessels. 2020 May;35(5):681-688. doi: 10.1007/s00380-019-01538-3. Epub 2019 Nov 18. Heart Vessels. 2020. PMID: 31741050
Neurological prognosis prediction upon arrival at the hospital after out-of-hospital cardiac arrest: R-EDByUS score.
Shimada T, Kawai R, Shintani A, Shibata A, Otsuka K, Ito A, Yamazaki T, Izumiya Y, Fukuda D, Yonemoto N, Tahara Y, Ikeda T; Japanese Circulation Society Resuscitation Science Study JCS-ReSS Group. Shimada T, et al. Among authors: shibata a. Resuscitation. 2024 Jul;200:110257. doi: 10.1016/j.resuscitation.2024.110257. Epub 2024 May 31. Resuscitation. 2024. PMID: 38823473 Free article.
Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction.
Hanatani A, Shibata A, Kitada R, Iwata S, Matsumura Y, Doi A, Sugioka K, Takagi M, Yoshiyama M. Hanatani A, et al. Among authors: shibata a. Heart Vessels. 2017 Mar;32(3):287-294. doi: 10.1007/s00380-016-0872-4. Epub 2016 Jul 6. Heart Vessels. 2017. PMID: 27385022 Clinical Trial.
1,733 results